Munoz X, Giner J, Sicras A, Lo Re D
Respir Care. 2024; 69(12):1534-1542.
PMID: 38906702
PMC: 11572995.
DOI: 10.4187/respcare.11643.
Talaat M, Si X, Xi J
Pharmaceuticals (Basel). 2022; 15(6).
PMID: 35745624
PMC: 9227885.
DOI: 10.3390/ph15060706.
Gleeson P, Feldman S, Apter A
J Allergy Clin Immunol Pract. 2020; 8(7):2234-2242.
PMID: 32173505
PMC: 7987134.
DOI: 10.1016/j.jaip.2020.03.003.
Biswas R, Hanania N, Sabharwal A
J Aerosol Med Pulm Drug Deliv. 2017; 30(4):256-266.
PMID: 28157430
PMC: 5564031.
DOI: 10.1089/jamp.2015.1278.
Shaw N, Le Souef P, Turkovic L, McCahon L, Kicic A, Sly P
Eur J Pediatr. 2016; 175(7):1007-12.
PMID: 27251668
DOI: 10.1007/s00431-016-2738-2.
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).
Levy M, Dekhuijzen P, Barnes P, Broeders M, Corrigan C, Chawes B
NPJ Prim Care Respir Med. 2016; 26:16017.
PMID: 27098045
PMC: 4839029.
DOI: 10.1038/npjpcrm.2016.17.
Use of pressurized bronchodilators.
Lawford P
J R Soc Med. 2010; 74(7):557-8.
PMID: 20894367
PMC: 1439035.
DOI: 10.1177/014107688107400730.
Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P, Hederer B, Austen G, Dewberry H, Meyer T
Int J Chron Obstruct Pulmon Dis. 2009; 3(4):763-70.
PMID: 19281091
PMC: 2650591.
The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
Smyth H, Beck V, Williams D, Hickey A
AAPS PharmSciTech. 2004; 5(1):E7.
PMID: 15198528
PMC: 2784858.
DOI: 10.1208/pt050107.
Standards for bioequivalence of inhaled products.
Chrystyn H
Clin Pharmacokinet. 1994; 26(1):1-6.
PMID: 8137595
DOI: 10.2165/00003088-199426010-00001.
Salbutamol: comparison of bronchodilating effect of inhaled powder and aerosol in asthmatic subjects.
Latimer K, Roberts R, Dolovich J, Hargreave F
Can Med Assoc J. 1982; 127(9):857-9.
PMID: 7139504
PMC: 1862216.
Comparative efficacy of different methods of nebulising terbutaline.
Pedersen J, Bundgaard A
Eur J Clin Pharmacol. 1983; 25(6):739-42.
PMID: 6363098
DOI: 10.1007/BF00542512.
Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique.
Fuller H
CMAJ. 1986; 135(6):625-9.
PMID: 3530417
PMC: 1491308.
Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
Lipworth B, Clark R, Dhillon D, BROWN R, McDevitt D
Br J Clin Pharmacol. 1988; 26(5):527-33.
PMID: 2849969
PMC: 1386629.
DOI: 10.1111/j.1365-2125.1988.tb05292.x.
The biochemical effects of high-dose inhaled salbutamol in patients with asthma.
Lipworth B, Clark R, Fraser C, McDevitt D
Eur J Clin Pharmacol. 1989; 36(4):357-60.
PMID: 2737227
DOI: 10.1007/BF00558295.
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
Lipworth B, BROWN R, McDevitt D
Br J Clin Pharmacol. 1989; 28(1):95-102.
PMID: 2570601
PMC: 1379975.
DOI: 10.1111/j.1365-2125.1989.tb03510.x.
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.
Lipworth B, McDevitt D, Struthers A
Br J Clin Pharmacol. 1989; 27(6):837-42.
PMID: 2547409
PMC: 1379812.
DOI: 10.1111/j.1365-2125.1989.tb03447.x.
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.
Lipworth B, McDevitt D
Eur J Clin Pharmacol. 1989; 36(3):239-45.
PMID: 2545455
DOI: 10.1007/BF00558154.
Effects, side effects and plasma concentrations of terbutaline in adult asthmatics after inhaling from a dry powder inhaler device at different inhalation flows and volumes.
Engel T, Scharling B, Skovsted B, Heinig J
Br J Clin Pharmacol. 1992; 33(4):439-44.
PMID: 1576070
PMC: 1381335.
DOI: 10.1111/j.1365-2125.1992.tb04064.x.